Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Moore

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Cancer Research|April 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung CancerJesse Boumelha, Andrea de Castro, Nourdine Bah, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|February 7, 2007
Diabetic foot disorders. A clinical practice guideline (2006 revision)Robert G Frykberg, Thomas Zgonis, David G Armstrong, et al.
Plos One|July 15, 2015
Sedimentation Pulse in the NE Gulf of Mexico following the 2010 DWH BlowoutGregg R Brooks, Rebekka A Larson, Patrick T Schwing, et al.
Nature Communications|September 25, 2024
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockadePanayiotis Anastasiou, Christopher Moore, Sareena Rana, et al.
Nature Communications|November 28, 2022
Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolismClaudio Bussi, Tiaan Heunis, Enrica Pellegrino, et al.
Cancer Research|June 8, 2026
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant SubclonesMona Tomaschko, KangBo Ng, Christopher Moore, et al.
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.
Cancer Cell|July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy ResistanceDaniël A Lionarons, David C Hancock, Sareena Rana, et al.
Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 19, 2022
Impact of Portal Hypertension on Adverse Events after Splenic Arterial Aneurysm EmbolizationAhsun Riaz, Pouya Entezari, Asad Malik, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Cancer Research|April 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung CancerJesse Boumelha, Andrea de Castro, Nourdine Bah, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|February 7, 2007
Diabetic foot disorders. A clinical practice guideline (2006 revision)Robert G Frykberg, Thomas Zgonis, David G Armstrong, et al.
Plos One|July 15, 2015
Sedimentation Pulse in the NE Gulf of Mexico following the 2010 DWH BlowoutGregg R Brooks, Rebekka A Larson, Patrick T Schwing, et al.
Nature Communications|September 25, 2024
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockadePanayiotis Anastasiou, Christopher Moore, Sareena Rana, et al.
Nature Communications|November 28, 2022
Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolismClaudio Bussi, Tiaan Heunis, Enrica Pellegrino, et al.
Cancer Research|June 8, 2026
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant SubclonesMona Tomaschko, KangBo Ng, Christopher Moore, et al.
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.
Cancer Cell|July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy ResistanceDaniël A Lionarons, David C Hancock, Sareena Rana, et al.
Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 19, 2022
Impact of Portal Hypertension on Adverse Events after Splenic Arterial Aneurysm EmbolizationAhsun Riaz, Pouya Entezari, Asad Malik, et al.
Pageof 14